| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |